Alphabet invested in bioprinting technology. The company put money into FluidForm. FluidForm makes living human tissues using 3D printing. This technology prints actual human cells. Alphabet sees big potential here. This could change medicine.
(Google’s parent company Alphabet invests in bioprinting technology)
FluidForm uses a special method. It prints tiny structures that hold cells together. This lets cells grow into real tissue. The goal is making tissues that work like natural ones. This is important for fixing damaged organs.
The investment helps FluidForm grow. Alphabet provided money for more research. FluidForm will use this money to improve its technology. They want to make bioprinting more useful for doctors. Real medical uses are the target.
Potential applications are significant. Printed tissues could test new drugs safely. They might repair injuries one day. Creating whole organs for transplants is the ultimate hope. This could save many lives waiting for donors.
Alphabet believes bioprinting is crucial. The company looks for advanced technologies. Solving big health problems is the aim. This investment fits that goal. Better treatments for patients are possible. Bioprinting offers a new path forward.
(Google’s parent company Alphabet invests in bioprinting technology)
The deal details are private. The exact amount Alphabet invested is not public. Both companies are excited about the partnership. They want to speed up development. Bringing bioprinting to hospitals is the shared vision. This work takes time. But the potential impact is very large. Alphabet continues exploring bold health solutions.